STOCK TITAN

[Form 4] Oscar Health, Inc. Insider Trading Activity

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Oscar Health insider reported a disposition of Class A common stock by Richard Scott Blackley, the company's Chief Financial Officer and director. On 09/02/2025 the filing shows 28,166 shares of Class A common stock were disposed of under transaction code F at a price of $16.66 per share. After the reported transaction, Mr. Blackley beneficially owned 1,376,169 shares. The filing explains 28,166 shares were withheld by the issuer to satisfy tax withholding on vested restricted stock units and that the post-transaction holdings include shares to be issued upon RSU vesting. The Form 4 was signed by an attorney-in-fact on 09/04/2025.

Un insider di Oscar Health ha segnalato una cessione di azioni ordinarie di Classe A da parte di Richard Scott Blackley, Chief Financial Officer e membro del consiglio della società. Il 02/09/2025 la comunicazione indica che sono state cedute 28.166 azioni di Classe A con codice di transazione F al prezzo di $16,66 per azione. Dopo l'operazione riportata, il signor Blackley deteneva beneficiariamente 1.376.169 azioni. La dichiarazione precisa che 28.166 azioni sono state trattenute dall'emittente per soddisfare le ritenute fiscali su unità azionarie ristrette (RSU) maturate e che la detenzione post-transazione include azioni che saranno emesse al momento della maturazione delle RSU. Il Modulo 4 è stato firmato da un procuratore il 04/09/2025.

Un insider de Oscar Health informó sobre la enajenación de acciones ordinarias Clase A por parte de Richard Scott Blackley, el director financiero y miembro del consejo de la compañía. El 02/09/2025 la presentación muestra que se dispusieron 28.166 acciones Clase A bajo el código de transacción F a un precio de $16,66 por acción. Tras la operación informada, el Sr. Blackley poseía beneficiamente 1.376.169 acciones. La presentación explica que 28.166 acciones fueron retenidas por el emisor para cubrir la retención fiscal sobre las unidades restringidas de acciones (RSU) que han vencido y que las tenencias posteriores a la transacción incluyen acciones que se emitirán al vencimiento de las RSU. El Formulario 4 fue firmado por un apoderado el 04/09/2025.

Oscar Health의 임원(insider)이 재무담당 최고책임자(CFO) 겸 이사인 Richard Scott Blackley의 클래스 A 보통주 처분을 신고했습니다. 2025-09-02 제출서에는 거래 코드 F로 클래스 A 보통주 28,166주가 주당 $16.66에 처분된 것으로 나타납니다. 신고된 거래 이후 Blackley 씨는 실질적으로 1,376,169주를 보유하고 있었습니다. 제출서에는 28,166주가 기성 제한주식단위(RSU)의 세금 원천징수를 충당하기 위해 발행사가 보유했으며, 거래 후 보유분에는 RSU가 성숙될 때 발행될 주식이 포함되어 있다고 설명되어 있습니다. Form 4는 2025-09-04에 대리인(법정대리인)에 의해 서명되었습니다.

Un initié d'Oscar Health a déclaré une cession d'actions ordinaires de Classe A par Richard Scott Blackley, le directeur financier et administrateur de la société. Le 02/09/2025, le dépôt indique que 28 166 actions de Classe A ont été cédées sous le code de transaction F au prix de 16,66 $ par action. Après la transaction déclarée, M. Blackley détenait bénéficiairement 1 376 169 actions. Le dépôt précise que 28 166 actions ont été retenues par l'émetteur pour couvrir la retenue fiscale sur des unités d'actions restreintes (RSU) acquises et que les détentions post-transaction incluent des actions qui seront émises lors de la vesting des RSU. Le Formulaire 4 a été signé par un mandataire le 04/09/2025.

Ein Insider von Oscar Health meldete die Veräußerung von Class-A-Stammaktien durch Richard Scott Blackley, den Finanzvorstand und Direktor des Unternehmens. In der Meldung vom 02.09.2025 sind 28.166 Class-A-Aktien unter Transaktionscode F zu einem Preis von $16,66 je Aktie veräußert worden. Nach der gemeldeten Transaktion hielt Herr Blackley wirtschaftlich 1.376.169 Aktien. Die Meldung erklärt, dass 28.166 Aktien vom Emittenten einbehalten wurden, um die steuerliche Einbehaltung für fällige Restricted Stock Units (RSU) zu erfüllen, und dass die Bestände nach der Transaktion Aktien enthalten, die bei der Vesting der RSU ausgegeben werden. Das Formular 4 wurde am 04.09.2025 von einem Bevollmächtigten unterzeichnet.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: CFO reported a routine tax-withholding sale of vested RSUs; holdings remain substantial at 1.38 million shares.

The transaction is recorded as a disposition under code F indicating shares were withheld to satisfy tax obligations tied to RSU vesting rather than an open-market sale by the insider. The reported price of $16.66 reflects the valuation used for the withholding. The resulting beneficial ownership of 1,376,169 shares shows continued insider exposure to company equity. This filing provides clarity on the nature of the transaction and changes in outstanding insider holdings.

TL;DR: Disclosure is timely and specific, identifying the CFO, transaction mechanics, and resulting ownership.

The Form 4 correctly identifies the reporting person as an officer and director and discloses that shares were withheld to satisfy tax withholding from vested RSUs. The signature by an attorney-in-fact is noted with date. From a governance perspective, this is a standard insider disclosure documenting compensation-related share withholding rather than voluntary disposal, supporting transparency in insider reporting obligations.

Un insider di Oscar Health ha segnalato una cessione di azioni ordinarie di Classe A da parte di Richard Scott Blackley, Chief Financial Officer e membro del consiglio della società. Il 02/09/2025 la comunicazione indica che sono state cedute 28.166 azioni di Classe A con codice di transazione F al prezzo di $16,66 per azione. Dopo l'operazione riportata, il signor Blackley deteneva beneficiariamente 1.376.169 azioni. La dichiarazione precisa che 28.166 azioni sono state trattenute dall'emittente per soddisfare le ritenute fiscali su unità azionarie ristrette (RSU) maturate e che la detenzione post-transazione include azioni che saranno emesse al momento della maturazione delle RSU. Il Modulo 4 è stato firmato da un procuratore il 04/09/2025.

Un insider de Oscar Health informó sobre la enajenación de acciones ordinarias Clase A por parte de Richard Scott Blackley, el director financiero y miembro del consejo de la compañía. El 02/09/2025 la presentación muestra que se dispusieron 28.166 acciones Clase A bajo el código de transacción F a un precio de $16,66 por acción. Tras la operación informada, el Sr. Blackley poseía beneficiamente 1.376.169 acciones. La presentación explica que 28.166 acciones fueron retenidas por el emisor para cubrir la retención fiscal sobre las unidades restringidas de acciones (RSU) que han vencido y que las tenencias posteriores a la transacción incluyen acciones que se emitirán al vencimiento de las RSU. El Formulario 4 fue firmado por un apoderado el 04/09/2025.

Oscar Health의 임원(insider)이 재무담당 최고책임자(CFO) 겸 이사인 Richard Scott Blackley의 클래스 A 보통주 처분을 신고했습니다. 2025-09-02 제출서에는 거래 코드 F로 클래스 A 보통주 28,166주가 주당 $16.66에 처분된 것으로 나타납니다. 신고된 거래 이후 Blackley 씨는 실질적으로 1,376,169주를 보유하고 있었습니다. 제출서에는 28,166주가 기성 제한주식단위(RSU)의 세금 원천징수를 충당하기 위해 발행사가 보유했으며, 거래 후 보유분에는 RSU가 성숙될 때 발행될 주식이 포함되어 있다고 설명되어 있습니다. Form 4는 2025-09-04에 대리인(법정대리인)에 의해 서명되었습니다.

Un initié d'Oscar Health a déclaré une cession d'actions ordinaires de Classe A par Richard Scott Blackley, le directeur financier et administrateur de la société. Le 02/09/2025, le dépôt indique que 28 166 actions de Classe A ont été cédées sous le code de transaction F au prix de 16,66 $ par action. Après la transaction déclarée, M. Blackley détenait bénéficiairement 1 376 169 actions. Le dépôt précise que 28 166 actions ont été retenues par l'émetteur pour couvrir la retenue fiscale sur des unités d'actions restreintes (RSU) acquises et que les détentions post-transaction incluent des actions qui seront émises lors de la vesting des RSU. Le Formulaire 4 a été signé par un mandataire le 04/09/2025.

Ein Insider von Oscar Health meldete die Veräußerung von Class-A-Stammaktien durch Richard Scott Blackley, den Finanzvorstand und Direktor des Unternehmens. In der Meldung vom 02.09.2025 sind 28.166 Class-A-Aktien unter Transaktionscode F zu einem Preis von $16,66 je Aktie veräußert worden. Nach der gemeldeten Transaktion hielt Herr Blackley wirtschaftlich 1.376.169 Aktien. Die Meldung erklärt, dass 28.166 Aktien vom Emittenten einbehalten wurden, um die steuerliche Einbehaltung für fällige Restricted Stock Units (RSU) zu erfüllen, und dass die Bestände nach der Transaktion Aktien enthalten, die bei der Vesting der RSU ausgegeben werden. Das Formular 4 wurde am 04.09.2025 von einem Bevollmächtigten unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Blackley Richard Scott

(Last) (First) (Middle)
75 VARICK STREET, 5TH FLOOR

(Street)
NEW YORK NY 10013

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Oscar Health, Inc. [ OSCR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
09/02/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 09/02/2025 F 28,166(1) D $16.66 1,376,169(2) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Reflects shares of Class A common stock withheld by the Issuer to satisfy tax withholding obligations incident to vesting of restricted stock units ("RSUs").
2. Includes shares to be issued in connection with the vesting of one or more restricted stock units.
Remarks:
/s/ Melissa Curtin, Attorney-in-fact 09/04/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did OSCR CFO Richard Scott Blackley report on Form 4?

The Form 4 reports a disposition of 28,166 Class A shares on 09/02/2025 under transaction code F, with a price of $16.66 per share.

Why were the 28,166 shares disposed of according to the filing?

The filing states the 28,166 shares were withheld by the issuer to satisfy tax withholding obligations incident to the vesting of restricted stock units.

How many shares does the reporting person own after the transaction?

After the reported transaction, the reporting person beneficially owned 1,376,169 shares of Class A common stock.

Who signed the Form 4 and when was it signed?

The Form 4 was signed by Melissa Curtin, Attorney-in-fact on 09/04/2025.

What is the relationship of the reporting person to Oscar Health (OSCR)?

The filing identifies Richard Scott Blackley as a Director and an Officer with the title Chief Financial Officer.
Oscar Health Inc

NYSE:OSCR

OSCR Rankings

OSCR Latest News

OSCR Latest SEC Filings

OSCR Stock Data

4.75B
212.61M
4.05%
76.86%
23.24%
Healthcare Plans
Hospital & Medical Service Plans
Link
United States
NEW YORK